NCT02499458View on ClinicalTrials.gov

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial CellsPrognostic BiomarkersPredictive Biomarkers
Interventions
OTHER

None- observational study

Trial Locations (1)

N6K 4L6

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
collaborator

London Health Sciences Centre

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER